Koppikar Utpal 4
4 · Atara Biotherapeutics, Inc. · Filed Aug 18, 2022
Insider Transaction Report
Form 4
Koppikar Utpal
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-08-16$5.04/sh−5,940$29,908→ 197,589 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.